ROGER M. PERLMUTTER - 02 Mar 2026 Form 4 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Role: Chief Executive Officer and Director, Director
Signature: /s/ Benjamin Thorner, Attorney-in-Fact
Issuer symbol: EIKN
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 17:00:48 UTC
Previous filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
PERLMUTTER ROGER M	Chief Executive Officer and Director, Director	C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE	/s/ Benjamin Thorner, Attorney-in-Fact	04 Mar 2026	0001184228

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EIKN	Stock Option (Right to Buy)	Award		+268,176		$0.000000^*	268,176	02 Mar 2026	Common Stock	268,176	$14.88	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.

Remarks:

Chief Executive Officer and Director